Visalytics
Visalytics
dismissed EB-2 (NIW)

Principal Systems Administrator

Clinical Research And Biopharmaceutical Services Company · 2025-03-27

Decision Date
2025-03-27
Location
United States
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The Beneficiary proposes to advance clinical trial work through the use of Artificial Intelligence (AI) technical frameworks, ensuring the seamless and secure operation of systems essential for AI-powered clinical development solutions. This endeavor aims to expedite regulatory approvals and optimize market penetration of new treatments.

Framework Evaluation

0 of 3 criteria met
1 The proposed endeavor has both substantial merit and national importance. Not Met

The Director found the endeavor had substantial merit but failed to establish national importance, lacking broader implications beyond the company or significant economic effects. The AAO concurred, finding insufficient evidence of broader impact beyond the company, significant positive economic effects, or substantial reduction of a national labor shortage in STEM fields.

2 The individual is well-positioned to advance the proposed endeavor. Not Met

The AAO declined to reach this prong as the first prong was dispositive.

3 On balance, it would benefit the United States to waive the job offer and labor certification requirements. Not Met

The AAO declined to reach this prong as the first prong was dispositive.

Why This Petition Was Denied

The appeal was dismissed because the Petitioner failed to establish the national importance of the proposed endeavor under Dhanasar's first prong. USCIS found insufficient evidence that the endeavor would have broader implications beyond the company, significant positive economic effects, or substantially reduce a national labor shortage in STEM fields. The decision did not reach the second and third prongs.

Similar Cases

Others

Pharmaceuticals

USCIS EB-2 (NIW) dismissed
2024-10-21
The Beneficiary proposes to streamline and ensure the quality of pharmaceutical research, development, and regulatory approval processes through the development, enhancement, and maintenance of cloud, DevOps, and database systems. This involves enhancing clinical data management systems to automate drug development, protect sensitive patient data, and integrate cloud and AI automation technologies to optimize the process.

Others

Healthcare · Brazil

USCIS EB-2 (NIW) rfe dismissed
2024-02-29
The Petitioner proposes to work as a healthcare professional and establish a company providing clinical laboratory services and quality control of blood components. The endeavor aims to serve small and medium-sized health centers, laboratories, and hospitals, particularly in healthcare professional shortage areas (HPSAs).

Others

Pharmaceuticals · India

USCIS EB-2 (NIW) dismissed
2024-11-18
The Beneficiary proposes to continue working as an Associate Director, Master Data Management (MDM) Implementation Lead for a pharmaceutical company. His endeavor involves developing, implementing, and managing digital platforms using AI and machine learning to optimize laboratory workflows, integrate clinical trial data, ensure data security, improve access to high-quality information, and accelerate drug research, development, and regulatory approval processes.

Research Scientist

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
2025-02-05
The petitioner proposes researching and developing new drugs for optimizing immune responses and treating immune-related diseases. This involves translational and clinical biomedical research, therapeutics discovery, and development.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-27.

Browse all cases

At a Glance

Outcome dismissed
Criteria Met 0 / 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist